Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NE compared with BIO: revenue, margins and what each company keeps, and the suppliers and customers both name
NE
Noble Corp plc
Change
Mkt cap
Revenue
Revenue
BIO
Bio-Rad Laboratories, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NE
Noble Corp plc
vs
BIO
Bio-Rad Laboratories, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NE, solid
BIO, dashed
Supply-chain overlap
Revenue flow
NE: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NE
9
XOM
Exxon Mobil Corporation ("ExxonMobil")
customer
TTE
TotalEnergies
customer
SHEL
Shell
customer
BP
BP
customer
5 more · NE chain
›
Shared
0
No shared counterparties.
Only BIO
2
BDSX
Biodesix
customer
IMDX
Insight Molecular Diagnostics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
NE
Noble Corp plc
Change
48.89
▲
+3.03%
· post 49.00
Mkt cap
$7.8B
Revenue
$729M
Q3 FY26
Revenue
$3.3B
FY25
BIO
Bio-Rad Laboratories, Inc.
Change
372.18
▼
−3.18%
· post 372.18
Closed
Oct 30 '26
Mkt cap
$10.0B
Revenue
$651M
Q2 FY26
Revenue
$2.6B
FY25
vs
Compare
Closed
Oct 30 '26
NE
Noble Corp plc
vs
BIO
Bio-Rad Laboratories, Inc.
48.89
▲
+3.03%
post 49.00
Price
372.18
▼
−3.18%
post 372.18
$7.8B
Mkt cap
$10.0B
Q3 FY26
$729M
Revenue
$651M
Q2 FY26
FY25
$3.3B
Revenue
$2.6B
FY25
Change
Change
NE
48.89
▲
+3.03%
vs
BIO
372.18
▼
−3.18%
Closed
Oct 30 '26